Nectin‐4 is frequently overexpressed in solid tumors, yet many PDT photosensitizers show poor water solubility and nonspecific uptake. A Nectin‐4‐targeted nanobody–chlorin e6 conjugate (NPC) improves aqueous solubility and selectively accumulates in Nectin‐4‐positive tumor cells.
Haodian Wan +10 more
wiley +1 more source
Large-Scale Production and Therapeutic Evaluation of Exosomes for Cancer Treatment. [PDF]
Kimiz-Gebologlu I, Oncel SS.
europepmc +1 more source
Abstract Objective To compare the dialysis efficiency parameters between new single‐needle dialysis and conventional double‐needle dialysis and to explore the optimal prescription parameters for single‐needle hemodialysis. Methods This study involved a prospective, cross‐over design. Eight patients were randomly divided into two cohorts, which received
Bin Zhao +8 more
wiley +1 more source
Combining bioaffinity-ultrafiltration with <i>in vivo</i> and <i>in vitro</i> analyses to identify and characterize α-glucosidase inhibitors from <i>Rosa roxburghii</i> Tratt. Fruit. [PDF]
Zhu M, Peng Z, Wang G.
europepmc +1 more source
Abstract Introduction Peritoneal solute transfer rates (PSTR) are reported to increase with time. Changes in PSTR were reviewed in long‐term peritoneal dialysis (PD) patients to determine whether lower glucose degradation products (low GDP) dialysates prevented an increase in PSTR. Methods PSTR was determined with a 4‐h peritoneal equilibrium test with
Andrew Davenport
wiley +1 more source
Systematic characterization of mammalian extracellular vesicles using nano-flow cytometry. [PDF]
Vyzourek BT +8 more
europepmc +1 more source
SGLT2 inhibitors in hemodialysis or peritoneal dialysis patients: rationale and state-of-the art. [PDF]
Minutolo R +3 more
europepmc +1 more source
A new survival prediction model and exploration of hemodialysis quality control indicators in incident hemodialysis patients. [PDF]
Chang H +9 more
europepmc +1 more source
Fluid removal intensity in intermittent hemodialysis for acute kidney injury: net ultrafiltration rate characterization and outcomes. [PDF]
Paxton LK +5 more
europepmc +1 more source

